Top 3 Companies Ruling the Global Pigmentation Disorder Treatment Market

SkinCeuticals International, Pierre Fabre Laboratories, and Obagi Medical Products Inc., among others, are significant players in the global pigmentation disorder treatment market.

The global pigmentation disorder treatment market is expected to grow at a CAGR of about 7.4% in the forecast period of 2022-2027. As per the analysis by Expert Market Research, the market is expected to be driven by the changing lifestyles and the growing prevalence of pigmentation disorder.

Pigmentation disorders encompass a wide variety of illnesses typically characterised by aberrant melanocyte density, melanin concentration, or both, resulting in abnormal skin pigmentation. Some of these disorders are prevalent, while others are rare. Hypopigmentation and hyperpigmentation are two pigmentation types. Hypopigmentation occurs when the pigment is diminished, but when the pigment is entirely gone, depigmentation develops, leaving the skin white. The increasing preference for skin-lightening products and the rising disposable incomes are anticipated to be major drivers of the pigmentation disorder treatment market.

An ageing population, increasing skin disease prevalence, rising smoking rates, and global warming are further contributing to the demand for pigmentation disorders treatment products. Additionally, advancements in tissue engineering and the emergence of novel techniques are expected to support the development of innovative skincare products facilitating pigmentation disorder treatment during the projected period.

In January 2021, Pierre Fabre collaborated with 360MedLink to introduce TAVIE Skin, the first virtual support platform for patients with metastatic melanoma. The app, developed by experts, aimed to support metastatic melanoma patients. TAVIE Skin intends to contribute to the improvement of patients' quality of life along their treatment pathway by offering a variety of tools.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Top 3 Players in the Global Pigmentation Disorder Treatment Market

SkinCeuticals International

SkinCeuticals International is a company based in the United States that aims to improve skin health. It offers various advanced and therapeutic skincare products that are extensively utilised by plastic surgeons, dermatologists, and well as medi-spas. The products offered by the company are formulated to reverse the symptoms of ageing, preserve healthy skin, and protect against potential harm. SkinCeuticals also offers clinically proven skin improvement formulations for personalised skincare regimens.

Pierre Fabre Laboratories

Laboratoires Pierre Fabre is a global pharmaceutical and cosmetics business, headquartered in France. Its major business lines include family healthcare, pharmaceuticals, and dermo-cosmetics. The company's operations are concentrated on the research, development, production, and marketing of cosmetics, prescription medications, and family health products. With 9,600 employees across the globe, the company’s revenue in 2021 was EUR 2.5 billion.

Obagi Medical products

Obagi Medical is a worldwide speciality pharmaceutical business that offers products to minimise skin damage, premature ageing, and hyperpigmentation acne, among others. The company’s products are mainly accessible via dermatologists, cosmetic surgeons, medical spas, and other skin care specialists. Moreover, it sells more than 100 products to nourish, brighten, protect, and improve skin texture and tone.

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.